Exploring the Potential of Selective FKBP51 Inhibitors on Melanoma: An Investigation of Their In Vitro and In Vivo Effects

By
Jamie Kang
-
0
1508
Researchers assessed in vitro and in vivo the efficacy against melanoma of selective small molecules targeting FKBP51, called SAFits.
[Cell Death Discovery]
Full Article